Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michelle Ludwig to Retrospective Studies

This is a "connection" page, showing publications Michelle Ludwig has written about Retrospective Studies.

 
Connection Strength
 
 
 
0.334
 
  1. Dalwadi S, Echeverria A, Jhaveri P, Bui T, Waheed N, Tran D, Bonnen M, Ludwig M. Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2020 11; 30(11):1684-1688.
    View in: PubMed
    Score: 0.044
  2. Dalwadi SM, Dorman C, Fisher SB, Bonnen M, Grubbs E, Ludwig MS. Risk of thyroid cancer after therapeutic irradiation in adult patients: An Age-Based surveillance, epidemiology, and end results analysis. Laryngoscope. 2020 08; 130(8):2081-2086.
    View in: PubMed
    Score: 0.042
  3. Hanania AN, Myers P, Yoder AK, Bulut A, Henry Yu Z, Eraj S, Bowers J, Bonnen MD, Echeverria A, Hall TR, Anderson ML, Ludwig M. Inversely and adaptively planned interstitial brachytherapy: A single implant approach. Gynecol Oncol. 2019 02; 152(2):353-360.
    View in: PubMed
    Score: 0.040
  4. Shumway JW, Ran R, McClusky J, Rafique Z, Dark C, Peacock WF, Cintron A, Ludwig M. Impact of rescheduling hydrocodone-combination products in an urban Texas county healthcare system. J Opioid Manag. 2018 Jul/Aug; 14(4):257-264.
    View in: PubMed
    Score: 0.039
  5. Jalloul RJ, Sharma S, Tung CS, O'Donnell B, Ludwig M. Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study. Int J Gynecol Cancer. 2018 06; 28(5):1003-1012.
    View in: PubMed
    Score: 0.038
  6. Echeverria A, Manley H, O'Donnell B, Asper J, Bonnen M, Ludwig M. Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System. Int J Gynecol Cancer. 2017 09; 27(7):1464-1471.
    View in: PubMed
    Score: 0.036
  7. Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. BMC Cancer. 2015 Mar 27; 15:190.
    View in: PubMed
    Score: 0.031
  8. Zhang R, Chavana A, Shi Y, Zhou B, Ugarte V, Sun B, Guo B, Kazemifar S, Echeverria A, Ludwig M, Owrangi A. Dosimetric comparison of high dose rate interstitial brachytherapy and stereotactic body radiotherapy as alternative treatment methods for advanced-stage cervical cancer. Biomed Phys Eng Express. 2026 Jun 19; 12(3).
    View in: PubMed
    Score: 0.017
  9. Sapienza LG, Guitmann G, Morris CG, Okunieff PG, Ludwig MS, Gomes MJL, Benrubi ID, Hew KE. A Systematic Study on Local Failure Events Post Chemoradiation Therapy for Cervical Cancer: Understanding the Impact of Baseline Lateral Anatomic Compartment Involvement. Int J Radiat Oncol Biol Phys. 2026 02 01; 124(2):366-375.
    View in: PubMed
    Score: 0.016
  10. Rishi A, Albuquerque KV, Jhingran A, Donovan EK, Horne ZD, Ludwig MS, Pathak P, Goldsberry R, Glaser SM, Garg A, Yin V, Fernandez DC, Beriwal S, Ahmed KA, Montejo ME. Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study. Gynecol Oncol. 2025 08; 199:1-9.
    View in: PubMed
    Score: 0.016
  11. Sapienza LG, Chapman CH, Jhavar S, Calsavara VF, Ludwig MS, Gomes MJL, Carvalho EF. Understanding Hydronephrosis Occurrence by an Individual-Kidney Level Analysis of all Events Postchemoradiation Therapy for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2025 10 01; 123(2):513-522.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)